Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Christopher Tse"'
Autor:
Barbara Breznik, Meng-Wei Ko, Christopher Tse, Po-Chun Chen, Emanuela Senjor, Bernarda Majc, Anamarija Habič, Nicolas Angelillis, Metka Novak, Vera Župunski, Jernej Mlakar, David Nathanson, Anahid Jewett
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-15 (2022)
“Super-charged” NK cells kill patient-derived glioblastoma stem-like cells (GSLCs) in 2D and 3D tumor models, secrete IFN-γ and upregulate the surface expression of CD54 and MHC class I in GSLCs.
Externí odkaz:
https://doaj.org/article/c555a83978a343d1b3e8050a04378dba
Autor:
Gustavo Garcia, Nikhil Chakravarty, Sophia Paiola, Estrella Urena, Priya Gyani, Christopher Tse, Samuel W. French, Moise Danielpour, Joshua J. Breunig, David A. Nathanson, Vaithilingaraja Arumugaswami
Publikováno v:
Cells, Vol 12, Iss 19, p 2384 (2023)
Glioblastoma (GBM), the most common primary malignant brain tumor, is a highly lethal form of cancer with a very limited set of treatment options. High heterogeneity in the tumor cell population and the invasive nature of these cells decrease the lik
Externí odkaz:
https://doaj.org/article/8926c3d6d90e4bebaeeb5b891a2f0d6c
Autor:
Jenna K. Minami, Danielle Morrow, Nicholas A. Bayley, Elizabeth G. Fernandez, Jennifer J. Salinas, Christopher Tse, Henan Zhu, Baolong Su, Rhea Plawat, Anthony Jones, Alessandro Sammarco, Linda M. Liau, Thomas G. Graeber, Kevin J. Williams, Timothy F. Cloughesy, Scott J. Dixon, Steven J. Bensinger, David A. Nathanson
Publikováno v:
Cancer Cell.
Autor:
Katalina Chan, Lisa D. Burry, Christopher Tse, Hannah Wunsch, Charmaine De Castro, David R. Williamson
Publikováno v:
The Annals of pharmacotherapy. 56(10)
Objective: The aim of this study was to synthesize evidence available on continuous infusion ketamine versus nonketamine regimens for analgosedation in critically ill patients. Data sources A search of MEDLINE, EMBASE, CINAHL, CDSR, and ClinicalTrial
Autor:
Nicholas Bayley, Christopher Tse, Jenna Minami, Henan Zhu, Weihong Yan, Lynn Baufeld, Laura Gosa, Lisa Ta, William Yong, Robert Prins, Timothy Cloughesy, Linda M Liau, Thomas G Graeber, David Nathanson
Publikováno v:
Neuro-Oncology. 24:vii280-vii280
Bulk tumor and single-cell RNA sequencing have revealed the remarkable molecular heterogeneity and plasticity of gliomas, leading to the definition of tumor subtypes and cellular states describing inter- and intra-tumoral levels of heterogeneity resp
Autor:
Jenna Minami, Nicholas Bayley, Christopher Tse, Henan Zhu, Jennifer Salinas, Danielle Morrow, William Yong, Timothy Cloughesy, Linda M Liau, Thomas G Graeber, David Nathanson
Publikováno v:
Neuro-Oncology. 24:vii275-vii275
Gliomas have been classified into molecular (proneural, classical, mesenchymal) and neurodevelopmental (astrocyte, mesenchymal, neural progenitor cell (NPC), oligodendrocyte progenitor cell (OPC)) subtypes describing inter- and intra-tumoral heteroge
Autor:
Barbara Breznik, Meng-Wei Ko, Christopher Tse, Po-Chun Chen, Emanuela Senjor, Bernarda Majc, Anamarija Habič, Nicolas Angelillis, Metka Novak, Vera Župunski, Jernej Mlakar, David Nathanson, Anahid Jewett
Publikováno v:
Communications biology. 5(1)
Glioblastomas remain the most lethal primary brain tumors. Natural killer (NK) cell-based therapy is a promising immunotherapeutic strategy in the treatment of glioblastomas, since these cells can select and lyse therapy-resistant glioblastoma stem-l
Autor:
Linda M. Liau, Thomas G. Graeber, Henan Zhu, Robert M. Prins, Christopher Tse, Laura Gosa, Lisa Ta, Lynn Baufeld, Timothy F. Cloughesy, Nicholas Bayley, David Nathanson, William H. Yong, Weihong Yan
Publikováno v:
Neuro Oncol
The derivation of model systems from patient tumors is a requisite for reproducible and high throughput translational cancer research. However, not all tumors can form a model and those that do often fail to capture the molecular diversity specific t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68b6183ebc5c99e5cb4f448cea80edd8
https://europepmc.org/articles/PMC7650995/
https://europepmc.org/articles/PMC7650995/
Autor:
Jonathan Tsang, Peter M. Clark, David Nathanson, Lynn Baufeld, Timothy F. Cloughesy, Lorenz M. Urner, Michael E. Jung, Kym F. Faull, Christopher Tse
Publikováno v:
Neuro Oncol
The epidermal growth factor receptor (EGFR) is altered in nearly 60% of glioblastoma (GBM) tumors, however, EGFR tyrosine kinase inhibitors (TKIs) have failed to improve outcomes for patients with GBM. This can be attributed to the inability of clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13658f64818c64ed26db09c2fa8e8fe8
https://europepmc.org/articles/PMC6847433/
https://europepmc.org/articles/PMC6847433/
Autor:
Laura Gosa, William H. Yong, Lynn Baufeld, Henan Zhu, Weihong Yan, David Nathanson, Lisa Ta, Nicholas Bayley, Linda M. Liau, Christopher Tse, Robert M. Prins, Timothy F. Cloughesy, Thomas G. Graeber
Publikováno v:
Neuro Oncol
Bulk tumor and single-cell RNA sequencing have revealed the remarkable molecular heterogeneity and plasticity of gliomas. This has led to the creation of tumor subtypes and cellular states describing inter- and intra-tumoral heterogeneity, respective